InvestorsHub Logo
Followers 29
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Re: Minding post# 134697

Monday, 11/17/2014 11:37:11 AM

Monday, November 17, 2014 11:37:11 AM

Post# of 414423
http://seekingalpha.com/article/2433325-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-on-q1-2015-results-earnings-call-transcript

Unidentified Analyst

Good morning. I had one question and then I’d like to follow-up with another one if there is time. In your 10-Q they mentioned something about some arbitration of Phentermine with precession dose. And I was just curious if that was going to have any impact on the supply and if there is going to be any potential fallout to that in terms of costs in that arbitration.

Doug Plassche - Executive Vice President-Operations
Okay, I don’t think it will, like any partners you have contract that says when you have disagreements you go to arbitration. We have filed to the arbitration, however, we have not gone to an arbitrator yet, our lawyers are discussing it among themselves. It has not affected the supply from us to (indiscernible) precision dose or the pricing. And we hope to conclude and resolve issues over the coming few months.

"This is our year!"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News